Filing Overview
Issuer identified in the filing: Agrify Corporation, not RYTHM, Inc. The Form 8-K reports events dated April 17, 2024 and was signed April 22, 2024.
The filing announces a merger term sheet with Nature’s Miracle Holding Inc. (Nasdaq: NMHI) and a related debt purchase term sheet involving company debt held by entities controlled by Agrify’s CEO and chairman.
Transaction and Key Financial Terms
| Item | Terms disclosed |
|---|---|
| Proposed merger | Nature’s Miracle expects to acquire Agrify through a reverse triangular merger or similar structure. Agrify would remain the surviving entity. |
| Share consideration | Agrify shareholders are expected to receive approximately 0.45 share of Nature’s Miracle common stock for each Agrify share, subject to customary adjustments. |
| Expected timing | Closing is expected no later than six months after execution of a definitive merger agreement, subject to closing conditions. |
| Product purchases | Nature’s Miracle agreed to purchase $500,000 of horticultural LED lighting goods, with a purchase order expected within 10 days of April 17, 2024, and at least $750,000 of such goods before merger closing, inclusive of the $500,000 order. |
| Senior Note | CP Acquisitions LLC will convert $2.0 million of approximately $15.0 million of outstanding principal. Nature’s Miracle would purchase $3.0 million of remaining principal at closing and acquire approximately $10.1 million of remaining principal and interest for $7.0 million in cash payable within 12 months after closing. |
| Junior Note | GIC Acquisition LLC will convert approximately $1.0 million of principal and may convert up to an additional $2.0 million at closing. Agrify would purchase the Junior Note for cash equal to its outstanding principal balance at closing. |
Conditions, Governance, and Management Commentary
- The merger remains subject to definitive documentation, satisfactory due diligence, approval by both companies’ boards, required shareholder approvals, purchase of specified outstanding debt, and effectiveness of an SEC Form S-4 registration statement.
- Debt-related transactions are also subject to definitive documentation, due diligence, Nature’s Miracle board approval, and approval of the merger agreement by both boards.
- Upon closing, Raymond Chang is expected to become president of Nature’s Miracle’s Agrify division and join its board. One additional Agrify director is expected to join the Nature’s Miracle board and must qualify as independent under Nasdaq rules.
- The filing does not provide revenue, net income, operating cash flow, margins, cash balances, liquidity ratios, or a consolidated debt balance beyond the specific notes described above.
Material Changes Versus Prior Period
The filing text does not provide comparative-period financial statements or operating results. The material development is the proposed merger, related equity consideration, product purchase commitment, and planned restructuring or purchase of specified debt.
Risks and Unusual Items
- The transaction is only at the term-sheet stage and may not result in a completed merger.
- Completion depends on multiple approvals, definitive agreements, due diligence, debt transactions, and SEC registration statement effectiveness.
- The proposed debt arrangements involve related parties because CP Acquisitions LLC and GIC Acquisition LLC are controlled by Raymond Chang, Agrify’s CEO and chairman.
- Shareholders’ final ownership and economic value may differ from the approximately 0.45 exchange ratio because of customary adjustments, transaction terms, and changes in Nature’s Miracle’s share price.
- The filing does not describe financing sources beyond the stated cash payments or provide details of the definitive merger agreement, purchase orders, or final debt documentation.
Investor Verification Checklist
- Confirm the issuer identity and ticker, because the supplied metadata references RYTHM, Inc., while the filing identifies Agrify Corporation and ticker AGFY.
- Verify execution and terms of the definitive merger agreement and related debt purchase documents.
- Confirm the final exchange ratio, required shareholder approvals, Form S-4 effectiveness, and anticipated closing date.
- Verify whether the $500,000 and minimum $750,000 product purchase commitments were completed and paid.
- Reconcile the Senior Note and Junior Note balances, conversions, interest, cash payments, and related-party disclosures.
- Review subsequent filings for completion, amendment, termination, or failure of the proposed transactions.